NCT00212082View on ClinicalTrials.gov

Gene Expression Profiles in Predicting Chemotherapy Response in Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 30, 2002

Conditions
Metastatic Breast Cancer
Interventions
DRUG

doxorubicin, docetaxel

Trial Locations (1)

Unknown

National University Hospital, Singapore

All Listed Sponsors
lead

National University Hospital, Singapore

OTHER

NCT00212082 - Gene Expression Profiles in Predicting Chemotherapy Response in Breast Cancer | Biotech Hunter | Biotech Hunter